Literature DB >> 20128595

Design and synthesis of potent and selective BACE-1 inhibitors.

Catarina Björklund1, Stefan Oscarson, Kurt Benkestock, Neera Borkakoti, Katarina Jansson, Jimmy Lindberg, Lotta Vrang, Anders Hallberg, Asa Rosenquist, Bertil Samuelsson.   

Abstract

Highly potent BACE-1 protease inhibitors have been developed from an inhibitors containing a hydroxyethylene (HE) core displaying aryloxymethyl or benzyloxymethyl P1 side chain and a methoxy P1' side chain. The target molecules were synthesized in good overall yields from chiral carbohydrate starting materials. The inhibitors show high BACE-1 potency and good selectivity against cathepsin D, where the most potent inhibitor furnishes BACE-1 K(i) << 1 nM and displays >1000-fold selectivity over cathepsin D.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20128595     DOI: 10.1021/jm901168f

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  7 in total

1.  Structure-Based Analysis of Cryptic-Site Opening.

Authors:  Zhuyezi Sun; Amanda Elizabeth Wakefield; Istvan Kolossvary; Dmitri Beglov; Sandor Vajda
Journal:  Structure       Date:  2019-12-03       Impact factor: 5.006

Review 2.  The structural evolution of β-secretase inhibitors: a focus on the development of small-molecule inhibitors.

Authors:  Stefania Butini; Simone Brogi; Ettore Novellino; Giuseppe Campiani; Arun K Ghosh; Margherita Brindisi; Sandra Gemma
Journal:  Curr Top Med Chem       Date:  2013       Impact factor: 3.295

3.  Identification of Cryptic Binding Sites Using MixMD with Standard and Accelerated Molecular Dynamics.

Authors:  Richard D Smith; Heather A Carlson
Journal:  J Chem Inf Model       Date:  2021-02-18       Impact factor: 4.956

Review 4.  Recent development of multifunctional agents as potential drug candidates for the treatment of Alzheimer's disease.

Authors:  Natalia Guzior; Anna Wieckowska; Dawid Panek; Barbara Malawska
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

Review 5.  Novel multitarget-directed tacrine derivatives as potential candidates for the treatment of Alzheimer's disease.

Authors:  Wen-Yu Wu; Yu-Chen Dai; Nian-Guang Li; Ze-Xi Dong; Ting Gu; Zhi-Hao Shi; Xin Xue; Yu-Ping Tang; Jin-Ao Duan
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

6.  β-Secretase (BACE1) inhibition causes retinal pathology by vascular dysregulation and accumulation of age pigment.

Authors:  Jun Cai; Xiaoping Qi; Norbert Kociok; Sergej Skosyrski; Alonso Emilio; Qing Ruan; Song Han; Li Liu; Zhijuan Chen; Catherine Bowes Rickman; Todd Golde; Maria B Grant; Paul Saftig; Lutgarde Serneels; Bart de Strooper; Antonia M Joussen; Michael E Boulton
Journal:  EMBO Mol Med       Date:  2012-08-20       Impact factor: 12.137

7.  Design and Synthesis of Hydroxyethylene-Based BACE-1 Inhibitors Incorporating Extended P1 Substituents.

Authors:  Veronica Sandgren; Marcus Bäck; Ingemar Kvarnström; Anders Dahlgren
Journal:  Open Med Chem J       Date:  2013-03-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.